⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171713 | 0.83 | — | — | |
| SCHEMBL69649 | 0.80 | — | — | |
| SCHEMBL9564316 | 0.80 | TSHR (0.46) | — | |
| SCHEMBL11267125 | 0.78 | TSHR (0.45) | — | |
| SCHEMBL37816440 | 0.72 | — | — | |
| SCHEMBL605558 | 0.72 | — | — | |
| SCHEMBL134755 | 0.72 | — | — | |
| SCHEMBL71077 | 0.72 | — | — | |
| SCHEMBL29455324 | 0.72 | — | — | |
| SCHEMBL30631964 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240262842-A1 | SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT | MERCK SHARP & DOHME LLC | 2024-08-08 | — | — | US | disclosed |
| EP-4329749-A1 | SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT | Merck Sharp & Dohme LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023016528-A1 | CLASS OF BENZOMORPHOLINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南京明德新药研发有限公司 | 2023-02-16 | — | — | WO | disclosed |
| CN-111349103-B | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-11-08 | — | — | CN | disclosed |
| CN-111499646-B | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-11-04 | — | — | CN | disclosed |
| WO-2022232318-A1 | SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT | MERCK SHARP & DOHME CORP. (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-112028902-B | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2022-10-28 | — | — | CN | disclosed |
| CN-112028902-A | Novel heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-12-04 | — | — | CN | disclosed |
| CN-111499646-A | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-08-07 | — | — | CN | disclosed |
| CN-111349103-A | Heterocyclic compound and organic light-emitting element using same | 株式会社LG化学 | 2020-06-30 | — | — | CN | disclosed |
| US-7928244-B2 | Isoxazolidine small molecules; cancer, hyperproliferation disorders; blocking antiapoptotic function | INFINITY DISCOVERY, INC. (US) | 2011-04-19 | — | — | US | disclosed |
| WO-2010092043-A1 | PHENOXY ACETIC ACID DERIVATIVES | MERCK SERONO S.A. (CH) | 2010-08-19 | — | — | WO | disclosed |
| CN-101663305-A | 2-amino-5, 7-dihydro-6H-pyrrolo [3, 4-D ] pyrimidine derivatives as HSP-90 inhibitors for the treatment of cancer | PFIZER | 2010-03-03 | — | — | CN | disclosed |
| CN-101400343-A | Modified release formulations containing drug-ion exchange resin complexes | TRIS PHARMA INC (US) | 2009-04-01 | — | — | CN | disclosed |
| US-20090023855-A1 | NOVEL CURABLE RESIN, PRODUCTION METHOD THEREOF, EPOXY RESIN COMPOSITION, AND ELECTRONIC DEVICE | RESONAC CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20080114167-A1 | Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners | INFINITY DISCOVERY, INC. (US) | 2008-05-15 | — | — | US | disclosed |
| US-20080114167-A1 | Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners | INFINITY DISCOVERY, INC. (US) | 2008-05-15 | — | — | US | disclosed |
| WO-2008024337-A2 | COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS | INFINITY DISCOVERY, INC. (US) | 2008-02-28 | — | — | WO | disclosed |
| CN-1852906-A | Novel compounds | SMITHKLINE BEECHAM CORP (US) | 2006-10-25 | — | — | CN | disclosed |
| CN-1085980-C | Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists | SEARLE & CO (US) | 2002-06-05 | — | — | CN | disclosed |